A STUDY USING VIRTUAL REALITY AS A SOURCE OF COMPLEMENTARY INFORMATION FOR NUCLEAR MEDICINE PATIENTS AND ITS RELATIVES by MENDONÇA, Sérgio F. et al.
 
2017 International Nuclear Atlantic Conference - INAC 2017 
Belo Horizonte, MG, Brazil, October 22-27, 2017 
ASSOCIAÇÃO BRASILEIRA DE ENERGIA NUCLEAR – ABEN 
  
 
 
A STUDY USING VIRTUAL REALITY AS A SOURCE OF 
COMPLEMENTARY INFORMATION FOR NUCLEAR MEDICINE 
PATIENTS AND ITS RELATIVES 
 
Sérgio F. Mendonça
1
, Ana C. H. Nascimento
2
, Antônio C. A. Mol
3
, Eugênio R. 
Marins
4
 and Júlio C. Suíta
5
 
          
                                  1,2,3,4,5 Instituto de Engenharia Nuclear- IEN/CNEN 
                              Rua Hélio de Almeida, 75 
                              Cidade Universitária, Ilha do Fundão 
                                              Rio de Janeiro 
                                      sergio.f2014@hotmail.com 
                                             acris@ien.gov.br 
                                              mol@ien.gov.br 
                                           eugenio@ien.gov.br 
                                             suita@ien.gov.br 
 
 
ABSTRACT 
 
This work consists in the research, analysis and unification of the guidelines transmitted to the patients 
and their relatives in the radioiodine therapy procedures. The goal is to provide greater understanding of 
the use of nuclear radiation and better understanding of treatment, to help patients better adapt to therapy, 
to demystify misconceptions about radiation use, and to improve care for their protection and for people 
close to them. Based on written and verbal information, collected in the scientific literature and  in loco 
accompanying the routine of the therapeutic rooms of Nuclear Medicine Services in Rio de Janeiro, the 
set of actions that define scenarios experienced by radioiodine therapy patients and their helpers is being 
generated. Based on this information, a virtual environment is being developed in the Virtual Reality 
Laboratory of the Institute of Nuclear Engineering (IEN / CNEN), a virtual environment that will allow 
the visualization of the procedures and instructions passed to the patients by the SMN1 teams. With this 
virtual environment, the patient will be able to perform an immersive visualization and to experience the 
different phases of the treatment, increasing the chances of efficiency of their participation in the process. 
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1. INTRODUCTION 
The radioiodine or iodine therapy used in the treatment of thyroid gland carcinoma aims 
to eliminate remaining thyroid tissue after surgery, thyroidectomy, and eliminate any 
metastases. With references in international recommendations, such as the publications 
of the International Atomic Energy Agency (IAEA) and standards established by the 
National Nuclear Energy Commission (CNEN), this work deals with safety and 
radiation protection aspects with the objective of promoting the optimization of 
radiological exposure, whether The patient, family members and caregivers, as well as 
the general public, in the treatment of thyroid cancer with iodine-131. 
 
1
SMN Nuclear Medicine Service 
Thus, a compilation and analysis of information about the routine of patients when 
hospitalized in the therapeutic room and the guidelines that are to be followed after their 
release is being prepared. This information will define scenarios in the virtual 
environment, under development in the Laboratory of Virtual Reality of the Institute of 
Nuclear Engineering (IEN), which will allow patients to know, in advance, the 
procedures and care of the treatment to be performed by themselves. 
 
 
2. NUCLEAR MEDICINE AND RADIOIODOTHERAPY 
 
Nuclear Medicine is a Medicine modality that uses ionizing radiation for the study of 
metabolic and functional anomalies in the human body. Its main property is the 
generation of images for diagnostic procedure of clinical pathologies. Below are 
illustrative examples:  tomographic image of brain, figure 1, whole body bone image, 
figure 2, and the third image is from a PT / CT scheme study comprising the fusion of 
the first two, figure 3. 
 
 
 
Figure 1. Tomographic imaging of brain study 
 
 
                 
 
  Figure 2. Full-Body Capture Study Image 
 
 
 
       Figure 3. PET / CT system image 
 
 
 
In the therapeutic procedure the objective is the use of the radiation emitted by the 
radiopharmaceutical in an organ of interest, for example, the use of radioiodine Iodine-
131, in the treatment of thyroid cancer (MINISTRY OF HEALTH 2017). 
Radiopharmaceuticals are chemical compounds, drugs, when attached to a radioisotope 
are used as therapeutic or diagnostic agents, the first determines the distribution profile 
around the organs of the body and the latter allows to determine their distribution in the 
body, (Murray, Peter 1998). The following figure shows some organs and tissues, their 
respective radiopharmaceuticals and its associated radioactive isotope: 
 
 
Figure 4. Radiopharmaceutical and its study organs. 
 
Radioisotope is an isotope of a specific element having unstable neutrons number, so 
that it undergoes spontaneous decay with the release of radioactive particles or energy. 
Radionuclide is a nuclide of artificial or natural origin that has an unstable configuration 
that acquires stability through radioactive decay (Murray, Peter 1998). The table below 
shows some of the main radioactive isotopes used in Nuclear Medicine, indicating the 
type of emission (type of radiation emitted) and the physical half-life of the 
radioisotope. 
 
 Table 1. Some physical properties of the radionuclides used in nuclear 
medicine 
 
 
 
 
 
 
2.1  Methods   
At first a review of the appropriate literature was done and the following articles and 
regulatory notes were taken into account: Nuclear Medicine in Clinical Diagnosis and 
Treatment [ref 3], Nuclear Medicine: a Manual for Students and Teachers [ref 4], 
Norma 3.05 of CNEN [Ref 5], and publications of the Nuclear Safety Series of IAEA 
[ref 6]. Specific article printed and available on the World Wide Web [ref 1] and [ref 2] 
were also analyzed and considered. With the knowledge acquired, on-site research was 
performed in a therapeutic room of the Nuclear Medicine Service, as well as interviews 
with professionals who work directly with the patients of the unit. We also used records 
of patient recommendations and observations available to the professionals and their 
patients [ref 7]. 
2.2 Results 
The information obtained and the studies performed show that the therapeutic room 
used in radioiodine therapy is a radioactive facility with some particularities that should 
be presented to the patients in a clear and objective way. For the practice of Nuclear 
Medicine, it is necessary that the facility be regularly registered in a competent 
institution, according to the legislation, and medical exposure situations are justified and 
planned (Bailey, Humm, Pokropek, Aswen, 2014). According to CNEN 3.05, the 
installations must have concrete walls and leaded door, to keep dose levels for workers 
and the public within the established limits. Pertinent signalization and areas 
classifications shall also be observed in accordance with the standards. To make the 
therapy safer, there must be a patient identification system in order to avoid possible 
accidents where patients receive double doses, for example. Care should also be taken 
to avoid exposure of patients who are pregnant or breastfeeding (IAEA). 
Recommendations for patients provided by SMN should include, among other 
recommendations, guidelines such as: after self-dosing the patient should not talk for 30 
minutes, drink water only one hour after the application, and feed after two hours. The 
hygienic care to be followed involves taking two to three baths a day, not walking 
barefoot around the room, washing hands constantly and never opening the exit door of 
the therapeutic room during confinement. The communication must be made by 
telephone. When delivering food, the patient must stay behind the shield. After hospital 
discharge, the patient should avoid contact with pregnant, children and pregnant and 
lactating women. He should sleep in a separate bed and keep a minimum distance of 2 
meters from other people he live with. These are some examples of the procedures and 
care needed. 
3. CONCLUSIONS 
 
Based on the compilation and analysis of the information collected in the scientific 
literature, guides and rules, as well as on-site information’s, it is expected that a built 
virtual environment can serve as a source of information and guidance for patients, their 
families and neighbors about therapeutics, thus acquiring better conditions in terms of 
radiological protection of those involved. 
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